It comes in five dose strengths : 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg
Lean tirzepatide when: Maximum weight loss is the goal (target greater than 20%) You have T2D with significant insulin resistance (SURPASS-2: 11.2 kg tirzepatide vs 5.7 kg semaglutide) You have moderate-to-severe obstructive sleep apnea with obesity (Zepbound is the only FDA-approved pharmacotherapy) You plateaued on semaglutide after 12+ months You have MASH and need the drug with the strongest resolution data (SYNERGY-NASH: 44 to 62% resolution) Your insurance covers Zepbound or Mounjaro You tolerated the 2.5 mg starting dose well during a prior trial Lean semaglutide when: You have established cardiovascular disease or high CV risk
TSA allows injectable medications through security
Warning signs include a rapid onset of symptoms affecting multiple body systems: skin reactions combined with breathing difficulties, a sudden drop in blood pressure causing dizziness or loss of consciousness, rapid heartbeat, and gastrointestinal symptoms such as severe abdominal cramping or vomiting
Impaired sperm quality : Studies have shown associations between elevated body mass index (BMI) and reduced sperm concentration, motility, and morphology
It comes in a single-use pen that you inject into your abdomen, thigh, or upper arm
